Lou H, Cote G J, Gagel R F
Department of Medical Specialties, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Mol Endocrinol. 1994 Dec;8(12):1618-26. doi: 10.1210/mend.8.12.7535892.
The primary transcript of the calcitonin (CT)/calcitonin gene-related peptide (CGRP) is alternatively spliced in a cell-specific fashion to produce CT in thyroid C cells and CGRP in neuronal cells. The key step in this regulatory process is the recognition and inclusion of exon 4 to produce CT mRNA or nonrecognition and exclusion of exon 4 to produce CGRP mRNA. To determine whether inclusion/exclusion of CT exon is regulated independently of its position, we created a series of minigene constructs containing decreasing amounts of CT gene sequence. A human glioblastoma cell line, T98G, was tested and used as a CT exon exclusion cell line, while HeLa cells were used as a CT exon inclusion cell line. CT exon inclusion/exclusion was regulated when either the relative position of exon 4 within the CT gene was changed or when the exon with flanking sequence was inserted into a completely heterologous gene. Our results demonstrate that CT exon functions as a unit in a position-independent fashion in regulating its own inclusion/exclusion. We believe that the heterologous fusion gene containing only exon 4 and part of its flanking intron sequences will be useful for further defining the sequence elements involved in the regulation of CT/CGRP splicing.
降钙素(CT)/降钙素基因相关肽(CGRP)的初级转录本以细胞特异性方式进行可变剪接,从而在甲状腺C细胞中产生CT,在神经元细胞中产生CGRP。这一调控过程的关键步骤是识别并包含外显子4以产生CT mRNA,或者不识别并排除外显子4以产生CGRP mRNA。为了确定CT外显子的包含/排除是否独立于其位置进行调控,我们构建了一系列包含递减量CT基因序列的微型基因构建体。对人胶质母细胞瘤细胞系T98G进行了测试,并将其用作CT外显子排除细胞系,而HeLa细胞则用作CT外显子包含细胞系。当CT基因中外显子4的相对位置改变,或者将带有侧翼序列的外显子插入到一个完全异源的基因中时,CT外显子的包含/排除受到调控。我们的结果表明,CT外显子在调控自身的包含/排除时,以位置独立的方式作为一个单元发挥作用。我们相信,仅包含外显子4及其部分侧翼内含子序列的异源融合基因,将有助于进一步确定参与CT/CGRP剪接调控的序列元件。